The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience – IL PSO (Italian Landscape Psoriasis)

Anti-interleukin 17 use has been associated with a higher risk of candidiasis, as this cytokine is involved in maintaining mucosal barriers and orchestrating immune responses to fungal pathogens. We performed a real-life retrospective multicentre study aiming to assess the risk of candidiasis in patients undergoing treatment with bimekizumab at labelled dosage for psoriasis, for at least 16 weeks.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Dermatology
Published
2024-10-07
DOI
https://doi.org/10.1093/ced/llae400
Citations
7
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
1.68
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience – IL PSO (Italian Landscape Psoriasis)

Giovanni Pellacani, Diego Orsini, Martina Maurelli, Luca Bianchi et al.
7 citations
Clinical and Experimental Dermatology
Psoriasis: Treatment and Pathogenesis
1.68
article

The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience – IL PSO (Italian Landscape Psoriasis)

Giovanni Pellacani, Diego Orsini, Martina Maurelli, Luca Bianchi, Giovanni Paolino, Anna Elisabetta Cagni, Francesco Loconsole, Andrea Michelerio, Angelo Valerio Marzano, Edoardo Mortato, Maria Esposito, Annunziata Dattola, Luigi Gargiulo, Matteo Megna, Claudia Lasagni, Annamaria Offidani, Francesco Cusano, Piergiorgio Malagoli, Enzo Errichetti, Anna Campanati, Pina Brianti, Dario Buononato, Paolo Dapavo, Chiara Assorgi, Marina Venturini, Santo Raffaele Mercuri, Vincenzo Maione, Valentina Dini, Antonio Costanzo, Giacomo Dal Bello, Antonio Giovanni Richetta, Carmen Silvia Fiorella, Anna Balato, Luca Potestio, Maria Concetta Fargnoli, Martina Burlando, Alessandra Michelucci, Luciano Ibba, Vito Giuseppe Di Lernia, Pietro Quaglino, Maria Teresa Uzzauto, D D’Amico, Riccardo Balestri, Pietro Morrone, Giacomo Caldarola, Andrea Carugno, Paolo Sena, Alessandro Giunta, Clara De Simone, Norma Cameli, Alessandra Narcisi, Alexandra Maria Giovanna Brunasso, Karin Chersi, Francesca Maria Gaiani, Elena Campione, Giampaolo Trevisan, Paolo Gisondi, Aurora Parodi, Alessandro Gatti, Francesca Romano, Carlo Giovanni Carrera, Antonio Foti
article en
7 citations

Abstract

Anti-interleukin 17 use has been associated with a higher risk of candidiasis, as this cytokine is involved in maintaining mucosal barriers and orchestrating immune responses to fungal pathogens. We performed a real-life retrospective multicentre study aiming to assess the risk of candidiasis in patients undergoing treatment with bimekizumab at labelled dosage for psoriasis, for at least 16 weeks.

Clinical and Experimental DermatologyVol. 50(4)
Università Cattolica del Sacro Cuore (IT), University of Insubria (IT), University of Rome Tor Vergata (IT), University of Verona (IT), University of Modena and Reggio Emilia (IT), Marche Polytechnic University (IT), University of Udine (IT), University of Salerno (IT), Humanitas University (IT), Vita-Salute San Raffaele University (IT), University of Milan (IT), University of Campania "Luigi Vanvitelli" (IT), University of Pavia (IT), University of L'Aquila (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Antonio Cardarelli (IT), Ospedale Santa Chiara (IT), Azienda Ospedaliera G.Rummo (IT), IRCCS Policlinico San Donato (IT), Azienda Ospedaliera di Cosenza (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Azienda Ospedaliera San Gerardo (IT), Azienda Ospedaliera S.Maria (IT), San Gallicano Hospital (IT), Ca' Foncello Hospital (IT), Ospedale Policlinico San Martino (IT), Azienda Ospedaliera Pugliese Ciaccio (IT), Policlinico San Matteo Fondazione (IT), Ospedale San Bortolo (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Villa Torri Hospital (IT), IRCCS Humanitas Research Hospital (IT), Azienda Sanitaria Universitaria Integrata di Trieste (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Turin (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 16%
Psoriasis: Treatment and Pathogenesis
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.